Web-accessible application for identifying pathogenic transcripts with RNA-seq: Increased sensitivity in diagnosis of neurodevelopmental disorders

For neurodevelopmental disorders (NDDs), a molecular diagnosis is key for management, predicting outcome, and counseling. Often, routine DNA-based tests fail to establish a genetic diagnosis in NDDs. Transcriptome analysis (RNA sequencing [RNA-seq]) promises to improve the diagnostic yield but has n...

Full description

Saved in:
Bibliographic Details
Published in:American journal of human genetics Vol. 110; no. 2; p. 251
Main Authors: Dekker, Jordy, Schot, Rachel, Bongaerts, Michiel, de Valk, Walter G, van Veghel-Plandsoen, Monique M, Monfils, Kathryn, Douben, Hannie, Elfferich, Peter, Kasteleijn, Esmee, van Unen, Leontine M A, Geeven, Geert, Saris, Jasper J, van Ierland, Yvette, Verheijen, Frans W, van der Sterre, Marianne L T, Sadeghi Niaraki, Farah, Smits, Daphne J, Huidekoper, Hidde H, Williams, Monique, Wilke, Martina, Verhoeven, Virginie J M, Joosten, Marieke, Kievit, Anneke J A, van de Laar, Ingrid M B H, Hoefsloot, Lies H, Hoogeveen-Westerveld, Marianne, Nellist, Mark, Mancini, Grazia M S, van Ham, Tjakko J
Format: Journal Article
Language:English
Published: United States 02.02.2023
Subjects:
ISSN:1537-6605, 1537-6605
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract For neurodevelopmental disorders (NDDs), a molecular diagnosis is key for management, predicting outcome, and counseling. Often, routine DNA-based tests fail to establish a genetic diagnosis in NDDs. Transcriptome analysis (RNA sequencing [RNA-seq]) promises to improve the diagnostic yield but has not been applied to NDDs in routine diagnostics. Here, we explored the diagnostic potential of RNA-seq in 96 individuals including 67 undiagnosed subjects with NDDs. We performed RNA-seq on single individuals' cultured skin fibroblasts, with and without cycloheximide treatment, and used modified OUTRIDER Z scores to detect gene expression outliers and mis-splicing by exonic and intronic outliers. Analysis was performed by a user-friendly web application, and candidate pathogenic transcriptional events were confirmed by secondary assays. We identified intragenic deletions, monoallelic expression, and pseudoexonic insertions but also synonymous and non-synonymous variants with deleterious effects on transcription, increasing the diagnostic yield for NDDs by 13%. We found that cycloheximide treatment and exonic/intronic Z score analysis increased detection and resolution of aberrant splicing. Importantly, in one individual mis-splicing was found in a candidate gene nearly matching the individual's specific phenotype. However, pathogenic splicing occurred in another neuronal-expressed gene and provided a molecular diagnosis, stressing the need to customize RNA-seq. Lastly, our web browser application allowed custom analysis settings that facilitate diagnostic application and ranked pathogenic transcripts as top candidates. Our results demonstrate that RNA-seq is a complementary method in the genomic diagnosis of NDDs and, by providing accessible analysis with improved sensitivity, our transcriptome analysis approach facilitates wider implementation of RNA-seq in routine genome diagnostics.
AbstractList For neurodevelopmental disorders (NDDs), a molecular diagnosis is key for management, predicting outcome, and counseling. Often, routine DNA-based tests fail to establish a genetic diagnosis in NDDs. Transcriptome analysis (RNA sequencing [RNA-seq]) promises to improve the diagnostic yield but has not been applied to NDDs in routine diagnostics. Here, we explored the diagnostic potential of RNA-seq in 96 individuals including 67 undiagnosed subjects with NDDs. We performed RNA-seq on single individuals' cultured skin fibroblasts, with and without cycloheximide treatment, and used modified OUTRIDER Z scores to detect gene expression outliers and mis-splicing by exonic and intronic outliers. Analysis was performed by a user-friendly web application, and candidate pathogenic transcriptional events were confirmed by secondary assays. We identified intragenic deletions, monoallelic expression, and pseudoexonic insertions but also synonymous and non-synonymous variants with deleterious effects on transcription, increasing the diagnostic yield for NDDs by 13%. We found that cycloheximide treatment and exonic/intronic Z score analysis increased detection and resolution of aberrant splicing. Importantly, in one individual mis-splicing was found in a candidate gene nearly matching the individual's specific phenotype. However, pathogenic splicing occurred in another neuronal-expressed gene and provided a molecular diagnosis, stressing the need to customize RNA-seq. Lastly, our web browser application allowed custom analysis settings that facilitate diagnostic application and ranked pathogenic transcripts as top candidates. Our results demonstrate that RNA-seq is a complementary method in the genomic diagnosis of NDDs and, by providing accessible analysis with improved sensitivity, our transcriptome analysis approach facilitates wider implementation of RNA-seq in routine genome diagnostics.
For neurodevelopmental disorders (NDDs), a molecular diagnosis is key for management, predicting outcome, and counseling. Often, routine DNA-based tests fail to establish a genetic diagnosis in NDDs. Transcriptome analysis (RNA sequencing [RNA-seq]) promises to improve the diagnostic yield but has not been applied to NDDs in routine diagnostics. Here, we explored the diagnostic potential of RNA-seq in 96 individuals including 67 undiagnosed subjects with NDDs. We performed RNA-seq on single individuals' cultured skin fibroblasts, with and without cycloheximide treatment, and used modified OUTRIDER Z scores to detect gene expression outliers and mis-splicing by exonic and intronic outliers. Analysis was performed by a user-friendly web application, and candidate pathogenic transcriptional events were confirmed by secondary assays. We identified intragenic deletions, monoallelic expression, and pseudoexonic insertions but also synonymous and non-synonymous variants with deleterious effects on transcription, increasing the diagnostic yield for NDDs by 13%. We found that cycloheximide treatment and exonic/intronic Z score analysis increased detection and resolution of aberrant splicing. Importantly, in one individual mis-splicing was found in a candidate gene nearly matching the individual's specific phenotype. However, pathogenic splicing occurred in another neuronal-expressed gene and provided a molecular diagnosis, stressing the need to customize RNA-seq. Lastly, our web browser application allowed custom analysis settings that facilitate diagnostic application and ranked pathogenic transcripts as top candidates. Our results demonstrate that RNA-seq is a complementary method in the genomic diagnosis of NDDs and, by providing accessible analysis with improved sensitivity, our transcriptome analysis approach facilitates wider implementation of RNA-seq in routine genome diagnostics.For neurodevelopmental disorders (NDDs), a molecular diagnosis is key for management, predicting outcome, and counseling. Often, routine DNA-based tests fail to establish a genetic diagnosis in NDDs. Transcriptome analysis (RNA sequencing [RNA-seq]) promises to improve the diagnostic yield but has not been applied to NDDs in routine diagnostics. Here, we explored the diagnostic potential of RNA-seq in 96 individuals including 67 undiagnosed subjects with NDDs. We performed RNA-seq on single individuals' cultured skin fibroblasts, with and without cycloheximide treatment, and used modified OUTRIDER Z scores to detect gene expression outliers and mis-splicing by exonic and intronic outliers. Analysis was performed by a user-friendly web application, and candidate pathogenic transcriptional events were confirmed by secondary assays. We identified intragenic deletions, monoallelic expression, and pseudoexonic insertions but also synonymous and non-synonymous variants with deleterious effects on transcription, increasing the diagnostic yield for NDDs by 13%. We found that cycloheximide treatment and exonic/intronic Z score analysis increased detection and resolution of aberrant splicing. Importantly, in one individual mis-splicing was found in a candidate gene nearly matching the individual's specific phenotype. However, pathogenic splicing occurred in another neuronal-expressed gene and provided a molecular diagnosis, stressing the need to customize RNA-seq. Lastly, our web browser application allowed custom analysis settings that facilitate diagnostic application and ranked pathogenic transcripts as top candidates. Our results demonstrate that RNA-seq is a complementary method in the genomic diagnosis of NDDs and, by providing accessible analysis with improved sensitivity, our transcriptome analysis approach facilitates wider implementation of RNA-seq in routine genome diagnostics.
Author Mancini, Grazia M S
Dekker, Jordy
Smits, Daphne J
Joosten, Marieke
Kievit, Anneke J A
de Valk, Walter G
Sadeghi Niaraki, Farah
Hoefsloot, Lies H
Wilke, Martina
Geeven, Geert
van Ierland, Yvette
van Unen, Leontine M A
Verheijen, Frans W
Saris, Jasper J
Verhoeven, Virginie J M
Huidekoper, Hidde H
van Veghel-Plandsoen, Monique M
van Ham, Tjakko J
Elfferich, Peter
van de Laar, Ingrid M B H
Williams, Monique
Douben, Hannie
Schot, Rachel
Bongaerts, Michiel
Nellist, Mark
Kasteleijn, Esmee
van der Sterre, Marianne L T
Hoogeveen-Westerveld, Marianne
Monfils, Kathryn
Author_xml – sequence: 1
  givenname: Jordy
  surname: Dekker
  fullname: Dekker, Jordy
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 2
  givenname: Rachel
  surname: Schot
  fullname: Schot, Rachel
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 3
  givenname: Michiel
  surname: Bongaerts
  fullname: Bongaerts, Michiel
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 4
  givenname: Walter G
  surname: de Valk
  fullname: de Valk, Walter G
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 5
  givenname: Monique M
  surname: van Veghel-Plandsoen
  fullname: van Veghel-Plandsoen, Monique M
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 6
  givenname: Kathryn
  surname: Monfils
  fullname: Monfils, Kathryn
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 7
  givenname: Hannie
  surname: Douben
  fullname: Douben, Hannie
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 8
  givenname: Peter
  surname: Elfferich
  fullname: Elfferich, Peter
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 9
  givenname: Esmee
  surname: Kasteleijn
  fullname: Kasteleijn, Esmee
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 10
  givenname: Leontine M A
  surname: van Unen
  fullname: van Unen, Leontine M A
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 11
  givenname: Geert
  surname: Geeven
  fullname: Geeven, Geert
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 12
  givenname: Jasper J
  surname: Saris
  fullname: Saris, Jasper J
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 13
  givenname: Yvette
  surname: van Ierland
  fullname: van Ierland, Yvette
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 14
  givenname: Frans W
  surname: Verheijen
  fullname: Verheijen, Frans W
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 15
  givenname: Marianne L T
  surname: van der Sterre
  fullname: van der Sterre, Marianne L T
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 16
  givenname: Farah
  surname: Sadeghi Niaraki
  fullname: Sadeghi Niaraki, Farah
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 17
  givenname: Daphne J
  surname: Smits
  fullname: Smits, Daphne J
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 18
  givenname: Hidde H
  surname: Huidekoper
  fullname: Huidekoper, Hidde H
  organization: Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 19
  givenname: Monique
  surname: Williams
  fullname: Williams, Monique
  organization: Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 20
  givenname: Martina
  surname: Wilke
  fullname: Wilke, Martina
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 21
  givenname: Virginie J M
  surname: Verhoeven
  fullname: Verhoeven, Virginie J M
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 22
  givenname: Marieke
  surname: Joosten
  fullname: Joosten, Marieke
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 23
  givenname: Anneke J A
  surname: Kievit
  fullname: Kievit, Anneke J A
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 24
  givenname: Ingrid M B H
  surname: van de Laar
  fullname: van de Laar, Ingrid M B H
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 25
  givenname: Lies H
  surname: Hoefsloot
  fullname: Hoefsloot, Lies H
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 26
  givenname: Marianne
  surname: Hoogeveen-Westerveld
  fullname: Hoogeveen-Westerveld, Marianne
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 27
  givenname: Mark
  surname: Nellist
  fullname: Nellist, Mark
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 28
  givenname: Grazia M S
  surname: Mancini
  fullname: Mancini, Grazia M S
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands
– sequence: 29
  givenname: Tjakko J
  surname: van Ham
  fullname: van Ham, Tjakko J
  email: t.vanham@erasmusmc.nl
  organization: Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 Rotterdam, the Netherlands. Electronic address: t.vanham@erasmusmc.nl
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36669495$$D View this record in MEDLINE/PubMed
BookMark eNpNUE1r3DAUFCUhX80f6KHo2ItdSba0dm8hpGkgJFBaelyerafdt3glR0-bsn8jv7gbmkJPM8wMMzDn4iimiEJ80KrWSrvPmxo261VtlDG1NrXS9p0407ZZVM4pe_QfPxXnzBultO5UcyJOG-dc3_b2TLz8wqGCcURmGiaUMM8TjVAoRRlSluQxFgp7iis5Q1mnFUYaZckQecw0F5a_qazl94erivHpi7yLY0Zg9JIxMhV6prKXFKUnWMXExDIFGXGXk8dnnNK8PSzAdPA5ZY-Z34vjABPj5RteiJ9fb35cf6vuH2_vrq_uq7G1tlS4UNBaHDxa7X3b9xCwa50NFoLDJrRoXPeqgNVhYaDHIbSN7Tp_MAbbmgvx6W_vnNPTDrkst8QjThNETDtemoXrjDG96g_Rj2_R3bBFv5wzbSHvl_9-NH8AJr18lA
CitedBy_id crossref_primary_10_1016_j_bbadis_2025_167854
crossref_primary_10_1186_s13023_025_03740_1
crossref_primary_10_1186_s13073_025_01494_w
crossref_primary_10_1111_epi_17780
crossref_primary_10_1111_epi_18279
crossref_primary_10_1016_j_ajhg_2024_03_007
crossref_primary_10_1111_cge_14650
crossref_primary_10_1111_cge_14574
crossref_primary_10_1136_jmg_2023_109470
crossref_primary_10_1038_s41525_024_00402_2
crossref_primary_10_1186_s13073_024_01331_6
crossref_primary_10_1002_jimd_12663
crossref_primary_10_1016_j_ajhg_2025_08_010
crossref_primary_10_1038_s41467_025_58210_w
crossref_primary_10_1038_s41431_025_01792_2
crossref_primary_10_1136_jmg_2023_109263
crossref_primary_10_1186_s13073_024_01381_w
crossref_primary_10_1016_j_ajhg_2024_05_005
crossref_primary_10_1186_s13073_024_01382_9
crossref_primary_10_1038_s41525_025_00502_7
crossref_primary_10_1186_s12967_025_06609_w
crossref_primary_10_1016_j_ymgme_2024_108511
crossref_primary_10_1038_s41431_025_01919_5
crossref_primary_10_1084_jem_20240546
crossref_primary_10_1016_j_gim_2025_101513
crossref_primary_10_1016_j_xhgg_2024_100327
crossref_primary_10_1038_s41431_024_01692_x
ContentType Journal Article
Copyright Copyright © 2022 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2022 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.ajhg.2022.12.015
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Biology
EISSN 1537-6605
ExternalDocumentID 36669495
Genre Journal Article
GroupedDBID ---
--K
--Z
-~X
0R~
0SF
123
1~5
23M
2WC
4.4
457
4G.
53G
5GY
62-
6J9
7-5
85S
AACTN
AAEDT
AAEDW
AAFTH
AAKRW
AALRI
AAMRU
AAVLU
AAWTL
AAXUO
ABJNI
ABMAC
ABOCM
ABVKL
ACGFO
ACGFS
ACGOD
ACNCT
ACPRK
ADBBV
ADEZE
ADVLN
AENEX
AEXQZ
AFRAH
AFTJW
AGKMS
AHMBA
AITUG
AKAPO
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
ASPBG
AVWKF
AZFZN
BAWUL
CGR
CS3
CUY
CVF
D0L
DIK
E3Z
EBS
ECM
ECV
EIF
F5P
FCP
FDB
FEDTE
GX1
HVGLF
HYE
IH2
IHE
IXB
JIG
KQ8
L7B
M41
NPM
O-L
O9-
OK1
P2P
PQQKQ
RCE
RNS
ROL
RPM
RPZ
SES
SJN
SSZ
TN5
TR2
TWZ
UHB
UKR
UNMZH
UPT
VQA
WH7
Z5M
ZCA
7X8
AAFWJ
ABDGV
ABUFD
ACVFH
ADCNI
AEUPX
AFPUW
AIGII
AKBMS
AKYEP
APXCP
EFKBS
ID FETCH-LOGICAL-c455t-e70a45ebde51dd499afe8465f5af6e3f4e268e846a51f72a9ebf43588de26b542
IEDL.DBID 7X8
ISICitedReferencesCount 28
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000965928500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1537-6605
IngestDate Sun Nov 09 09:14:05 EST 2025
Wed Feb 19 02:22:43 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords RNA-sequencing
transcriptomics
molecular diagnostics
mRNA splicing
neurodevelopmental disorder
web browser application
Language English
License Copyright © 2022 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c455t-e70a45ebde51dd499afe8465f5af6e3f4e268e846a51f72a9ebf43588de26b542
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://www.cell.com/article/S0002929722005493/pdf
PMID 36669495
PQID 2768222909
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2768222909
pubmed_primary_36669495
PublicationCentury 2000
PublicationDate 2023-02-02
PublicationDateYYYYMMDD 2023-02-02
PublicationDate_xml – month: 02
  year: 2023
  text: 2023-02-02
  day: 02
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle American journal of human genetics
PublicationTitleAlternate Am J Hum Genet
PublicationYear 2023
SSID ssj0011803
Score 2.5493054
Snippet For neurodevelopmental disorders (NDDs), a molecular diagnosis is key for management, predicting outcome, and counseling. Often, routine DNA-based tests fail...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 251
SubjectTerms Cycloheximide
Gene Expression Profiling
Humans
Neurodevelopmental Disorders - diagnosis
Neurodevelopmental Disorders - genetics
RNA-Seq
Sequence Analysis, RNA - methods
Title Web-accessible application for identifying pathogenic transcripts with RNA-seq: Increased sensitivity in diagnosis of neurodevelopmental disorders
URI https://www.ncbi.nlm.nih.gov/pubmed/36669495
https://www.proquest.com/docview/2768222909
Volume 110
WOSCitedRecordID wos000965928500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA7qKnjx_VhfRPAabNOmDy-yiOJByyKKe1uSZqIVaXftKvg3_MVO0i7rRRC89NASCOlk8s3Ml_kIOUGP52s8SVnkqYiFQiqWmBRYIENPSsN5DK5l_k2cZclgkPbbhFvd0iqnPtE5al3lNkd-yhEXW-1pLz0fjZlVjbLV1VZCY550AoQyltIVD2ZVBD9xysi4qWMWIW5vL800_C758vyE8SHnLh3oi98hpjtqrlb_O8k1stKCTNprrGKdzEG5QZYa2cnPTfL1CIpJp5RYqFegP4rYFDEsLdzlXXcBilrF4gqNrMjpxB5rzsnU1KZv6V3WYzWMzyg6GcttB01ry4dvBCloUVLdEPmKmlaGutaZekZSwhnqtvdnvUUeri7vL65Zq83A8lCICYPYk6EApUH4WmPYJA0glBFGSBNBYELgUWLfSOGbmMsUlEFkliQaPygR8m2yUFYl7BLqGcW1TCIjENzlaCERhCKQgfCMpxNpuuR4uthDtH1b0JAlVO_1cLbcXbLT_LHhqGnSMQwwLksx-tv7w-h9smxV5B0Zmx-QjsGdD4dkMf-YFPXbkTMqfGb922_cB9tz
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Web-accessible+application+for+identifying+pathogenic+transcripts+with+RNA-seq%3A+Increased+sensitivity+in+diagnosis+of+neurodevelopmental+disorders&rft.jtitle=American+journal+of+human+genetics&rft.au=Dekker%2C+Jordy&rft.au=Schot%2C+Rachel&rft.au=Bongaerts%2C+Michiel&rft.au=de+Valk%2C+Walter+G&rft.date=2023-02-02&rft.issn=1537-6605&rft.eissn=1537-6605&rft.volume=110&rft.issue=2&rft.spage=251&rft_id=info:doi/10.1016%2Fj.ajhg.2022.12.015&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1537-6605&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1537-6605&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1537-6605&client=summon